If you have been reading about Reversed-phase HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-30. Numbers and descriptions here follow the published literature rather than marketing material.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.
Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its four N-terminal residues reproduce tuftsin, a tetrapeptide fragment of the immunoglobulin heavy chain, while the C-terminal Pro-Gly-Pro extension is a synthetic addition. The peptide has a molecular mass near 752 daltons and carries a net positive charge at physiological pH because of the arginine and lysine side chains. Published indexes list it under the name Selank and the sequence abbreviation TKPRPGP. Solid-phase peptide synthesis is the standard production route for research quantities.
| Property | Value | Notes |
|---|---|---|
| Primary route studied | Intranasal | Also examined parenterally in animal work |
| Reported plasma half-life | Minutes to tens of minutes | Values vary widely between reports |
| Main model systems | Rodent behavioural and cell assays | Human trials are few and small |
| Principal proposed targets | GABA-A receptor, GABA transaminase | Monoamine and neurotrophic pathways also reported |
| Evidence grade | Preliminary | Limited independent replication |
Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.
Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
=== Depression === A comparative meta-analysis of 21 major antidepressants found that venlafaxine, agomelatine, amitriptyline, escitalopram, mirtazapine, paroxetine, and vortioxetine were more effective than other antidepressants, although the quality of many comparisons was assessed as low or very low. Open-label evidence also suggests potential benefit in treatment-resistant cases: in a multicenter Canadian study of adults with inadequate response to prior antidepressants (n=159), 58% achieved response and 28% remission after 8 weeks of venlafaxine (mean 260 mg/day); tolerability was generally acceptable. Venlafaxine was similar in efficacy to the atypical antidepressant bupropion; however, the remission rate was lower for venlafaxine. In a double-blind study, patients who did not respond to an SSRI were switched to either venlafaxine or another SSRI (citalopram); similar improvement was observed in both groups. Studies have not established its efficacy for use in pediatric populations. In children and adolescents with depression, venlafaxine increases the risk of suicidal thoughts or attempts. Higher doses (e.g., 225 mg and 375 mg per day) of venlafaxine are more effective than lower doses (e.g., 75 mg per day) but also cause more side effects. Studies have shown that the extended-release is superior to the immediate-release form of venlafaxine. A 2017 meta-analysis has shown that the efficacy of venlafaxine is not correlated with baseline severity of depression.
=== Lyrics and themes === Since their first album, they have tackled subjects viewed from a nihilistic and cynical angle: alcohol abuse, drug use, suicidal thoughts, mental illness, alienation, loneliness, addiction, suicide, and death. They have addressed topics they have directly observed, as well as others drawn from tangible reality, or from their loved ones' experiences. The lyrics deal predominantly with personal subjects, as Toufouti has not been inclined to "talk about things that are a little too made up". They preferred to stick to topics they knew well, as they considered this approach enabled them to remain "authentic". To assert their "own identity" through their place of origin, namely Paris, the group incorporated "typical French references" as well as artwork featuring the Apaches, who were gangs of violent Parisian thugs from the 20th-century criminal underworld. The cover artwork of This Is Not Supposed To Be Positive depicts French executioner Anatole Deibler. The song title in French, "Le rouge pour le sang, le bleu pour la grâce" (lit. 'Red for Blood, Blue for Grace'), refers to the colour codes used by Deibler in his notebook, which listed the names of those condemned to the guillotine with a red cross circled in black and those pardoned with a blue cross. The French title of the instrumental song, "Les enfants des monstres pleurent leur désespoir" (lit. 'The Monsters' Children Weep Their Despair'), appearing on that album, originates from a documentary about [Gérard] Depardieu and his son's death.
=== Peru === The travelers gradually descended into the cinchona forests and former Inca territories. In Riobamba, they stayed with Montufar’s brother, where Humboldt accessed rare sixteenth-century manuscripts written in an extinct dialect and later translated into Spanish. These documents described pre-conquest events and the major eruption of Nevado de Altar volcano, which affected nearby towns with ash for seven years. Traveling from Riobamba to Cuenca across the Paramo of Azuay, Humboldt studied the remains of the Inca road, notable for its precise porphyry paving and straightness, comparable to Roman roads, leading to Cuzco. He also visited the ruins of Inca Tapayupangi’s palace and its summer house carved from rock, which offered impressive views and prompted Humboldt to admire Inca public works. Southward, the group had to ford the Rio Guancabamba, a tributary of the Amazon, twenty-seven times. Although not wide, the river’s strong current endangered their mules, which carried important collections. Humboldt described the anxiety of watching their passage. Further along, he observed the local postal system known as “el correo que nada,” where a messenger swam downstream with mail secured in a cotton handkerchief, sometimes using a balsa log to rest and stopping at huts for food and shelter. Humboldt confirmed the reliability of this system, having received mail sent this way in Paris, and noted that groups of people also traveled the river in this manner.
=== Hydrostatic skeleton === A hydrostatic skeleton uses hydrostatic pressure generated from muscle contraction against a liquid filled cavity. The liquid filled cavity is commonly referred to as the hydrostatic body. The liquid within the hydrostatic body acts as an incompressible fluid and the body wall of the hydrostatic body provides a passive elastic antagonist to muscle contraction, which in turn generates a force, which in turn creates movement. This structure plays a role in invertebrate support and locomotor systems and is used for the tube feet in starfish and body of worms. A specialized version of the hydrostatic skeleton is a called a muscular hydrostat, which consists of a tightly packed array of three-dimensional muscle fibers surrounding a hydrostatic body. Examples of muscular hydrostats include the arms of octopus and elephant trunks.
Sources: en.wikipedia.org
Hertz (1939), operations research scholar known for pioneering the Monte Carlo methods in finance Victor Wouk (1939), pioneer in the development of electric and hybrid vehicles Julius Ashkin (1940), nuclear physicist, brother of Arthur Ashkin '47 Jeremiah Stamler (1940), epidemiologist, expert in the field of preventive cardiology, professor emeritus at Northwestern University Ulrich P. Strauss (1941), chemist at Rutgers University, 1971 Guggenheim Fellow Bruce Wallace (1941), geneticist, professor at Virginia Tech Robert S. Wallerstein (1941), psychoanalyst and former president of the International Psychoanalytical Association and director of the Langley Porter Psychiatric Institute, brother of political scientist Immanuel Wallerstein '51 Kimball Chase Atwood III (1942), geneticist, professor at Columbia University Medical School Leon Davidson (1942), chemical engineer known for his work in the Manhattan Project and the study of Unidentified Flying Objects Karl Koopman (1943), chiropterologist and curator at the American Museum of Natural History Robert G.
Hydrofibers: A derivative of hydrocolloid dressings, hydrofibers are able to absorb up to 25 times their weight in fluid, making them the most absorbent dressing. They are much like alginate dressings in their absorptive capacity and tendency to form a gel upon contact with liquid. Medicated dressings: Many dressings come impregnated with medication, typically antimicrobial agents or debriding chemicals. Silver, iodine, growth hormones, enzymes, and antibacterial agents are most common. Negative-pressure wound therapy (NPWT): A unique type of dressing which consists of a foam dressing surrounded with an airtight film and then connected to power-assisted vacuum suction, creating a negative pressure environment over the wound. This negative pressure environment is thought to promote formation of granulation tissue and decrease inflammatory fluid. NPWT has the added benefit of requiring less frequent dressing changes, a process that is often painful for patients. Since its implementation, NPWT has been implemented broadly for chronic non-healing wounds but can also be applied to acute wounds that cannot be closed primarily due to swelling or concern for infection. This type of dressing is typically applied in the operating room but can be done at bedside with appropriate analgesia.
A cannabinoid receptor modulator is a compound that bind to the cannabinoid receptors, which are receptors in the human body that regulate multiple physiological responses, including pain sensation, mood regulation, and appetite. The two main targets of cannabinoid receptors modulators are cannabinoid receptor 1 (CBR1) and cannabinoid receptor 2 (CBR2). By stimulating or inhibiting these receptors, the modulators can achieve different therapeutic effects, such as relieving pain, reducing vomiting, improving appetite and maintaining muscle tone. Dronabinol, nabiximol, cannabidiol and nabilone are cannabinoid receptor modulators marketed as drugs for various therapeutic uses. These drugs also share some common adverse effects, including dizziness, headache, alteration in mental state, and diarrhoea. Recent research studies have explored other therapeutic potentials of the modulators, such as the antitumor effect of cannabidiol. Other cannabinoid receptor modulators are also under investigations.
Sources: en.wikipedia.org
=== Phase 1 === ABL-301 (SAR-446159) – bispecific antibody against α-synuclein [72] ALS-205 (PMX-205) – complement C5a receptor antagonist [73] ALX-001 (BMS-984923) – metabotropic glutamate mGlu5 receptor silent allosteric modulator [74] ARV-102 – leucine-rich repeat kinase 2 (LRRK2) inhibitor [75] ATH-399A (DWP-307399; HL-192) – nuclear receptor subfamily 4 group A member 2 (NR4A2) agonist [76] CT-2500 – undefined mechanism of action [77] FB-418 – Bcr-Abl tyrosine kinase inhibitor and leucine-rich repeat kinase 2 (LRRK2) inhibitor [78] GT-02287 – β-glucocerebrosidase (GCase) activator and/or chaperone [79] HL-400 – NLR family pyrin domain containing 3 (NLRP3) inhibitor [80] HNC-364 (rasagiline prodrug) – monoamine oxidase B (MAO-B) inhibitor [81] Human amniotic epithelial cell therapy - Shanghai iCELL Biotechnology (hAECs; hAESCs) – cell replacement [82] JNJ-0376 – undefined mechanism of action [83] JX-2105 – undefined mechanism of action [84] Lu AF28996 (Lu AF-28996) – dopamine D1 and D2 receptor agonist [85] LY-3962681 – RNA interference and α-synuclein expression modulator [86] MEDI-1341 (TAK-341) – monoclonal antibody against α-synuclein [87] NEU-723 – leucine-rich repeat kinase 2 (LRRK2) inhibitor [88] NN-9001 – undefined mechanism of action [89] PK-081 – α-synuclein degrader [90] Selnoflast (NLRP3i; RG-6418; RO-7486967; Somalix) – NLR family pyrin domain containing 3 (NLRP3) inhibitor inhibitor [91] TRN-501 – undefined mechanism of action [92] VQ-101 – glucosylceramidase stimulant [93] WID-2301 – undefined mechanism of action [94] WIT-2001 – undefined mechanism of action [95]
This time, the internet amplified the proposition and spawned a hundred frauds and scams. However, their adoption of the "HGH" term has provided an easy way to distinguish the hype from the evidence. In 2003, growth hormone hit the news again, when the US FDA granted Eli Lilly approval to market Humatrope for the treatment of idiopathic short stature. The indication was controversial for several reasons, the primary one being the difficulty in defining extreme shortness with normal test results as a disease rather than the extreme end of the normal height range Recombinant growth hormone available in the U.S. (and their manufacturers) include Nutropin (Genentech), Humatrope (Eli Lilly and Company), Genotropin (Pfizer), Norditropin (Novo Nordisk), Tev-Tropin (Teva) and Saizen (Merck Serono). The products are nearly identical in composition, efficacy, and cost, varying primarily in the formulations and delivery devices. Somapacitan-beco (Sogroya) is the first once-per week subcutaneous human growth hormone (hGH) therapy that was approved in the United States. It was approved for medical use in the United States in August 2020.
After Joe Biden announced Deb Haaland as his nominee for U.S. Interior Secretary, Stansbury announced her campaign for the special election to fill the seat. In the first round of voting by the state Democratic committee, Stansbury placed second after state Senator Antoinette Sedillo Lopez and automatically advanced to the runoff. In the second round of voting, she defeated Sedillo Lopez by six votes. As no Republican had represented the district since 2009, The Santa Fe New Mexican labeled her "a heavy favorite". She defeated state Senator Mark Moores and former state Lands Commissioner Aubrey Dunn Jr. in the June 1 election in a landslide. Her margin of victory was slightly larger than President Biden's 23-point victory in the district in 2020, and significantly larger than Deb Haaland's in 2020 for the House.
Sources: en.wikipedia.org
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.
The peptide enters plasma rapidly and is broken down by ordinary proteases into amino acids and shorter fragments. Reported half-lives are short. Whether meaningful amounts of the intact molecule reach the brain is an open question.
Most clinical reports are small, published in Russian and not independently replicated. English-language reviews highlight the absence of large randomised trials. Conclusions about efficacy should be treated as provisional.
Selank is a seven-amino-acid peptide built from the tuftsin sequence plus a Pro-Gly-Pro tail. It is produced by chemical synthesis rather than extracted from a natural source. The free peptide is usually supplied as a lyophilised powder or in an aqueous formulation.